MD3446F1 - Method of HIV infection treatment - Google Patents

Method of HIV infection treatment

Info

Publication number
MD3446F1
MD3446F1 MDA20060233A MD20060233A MD3446F1 MD 3446 F1 MD3446 F1 MD 3446F1 MD A20060233 A MDA20060233 A MD A20060233A MD 20060233 A MD20060233 A MD 20060233A MD 3446 F1 MD3446 F1 MD 3446F1
Authority
MD
Moldova
Prior art keywords
hiv infection
infection treatment
pacovirine
months
administered
Prior art date
Application number
MDA20060233A
Other languages
Romanian (ro)
Other versions
MD3446G2 (en
Inventor
Constantin Spinu
Victor Pantea
Lilia COJUHARI
Lucia LUCA
Pavel Chintea
Igor Spanu
Original Assignee
Centrul National Stiintifico-Practic De Medicina Preventiva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul National Stiintifico-Practic De Medicina Preventiva filed Critical Centrul National Stiintifico-Practic De Medicina Preventiva
Priority to MDA20060233A priority Critical patent/MD3446G2/en
Publication of MD3446F1 publication Critical patent/MD3446F1/en
Publication of MD3446G2 publication Critical patent/MD3446G2/en

Links

Abstract

The invention refers to medicine, namely to the infectious diseases. The method of HIV infection treatment consists in that it is administered pacovirine in a dose of 50 mg 2 times a day per os during 6 months.
MDA20060233A 2006-09-21 2006-09-21 Method of HIV infection treatment MD3446G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060233A MD3446G2 (en) 2006-09-21 2006-09-21 Method of HIV infection treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060233A MD3446G2 (en) 2006-09-21 2006-09-21 Method of HIV infection treatment

Publications (2)

Publication Number Publication Date
MD3446F1 true MD3446F1 (en) 2007-12-31
MD3446G2 MD3446G2 (en) 2008-10-31

Family

ID=38917509

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060233A MD3446G2 (en) 2006-09-21 2006-09-21 Method of HIV infection treatment

Country Status (1)

Country Link
MD (1) MD3446G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD27Z (en) * 2008-10-24 2010-01-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method for treating disorders of cellular immunity caused by the ionizing radiation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2700C2 (en) * 2004-07-01 2005-10-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)
MD20050015A (en) * 2005-01-14 2006-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of diminishing the immune response intensity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD27Z (en) * 2008-10-24 2010-01-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method for treating disorders of cellular immunity caused by the ionizing radiation

Also Published As

Publication number Publication date
MD3446G2 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
CY1116727T1 (en) Multiple Sclerosis Treatment With LAQUINIMOD
NZ586751A (en) Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
NZ589445A (en) Rasagiline for parkinson's disease modification
MX2012007410A (en) Novel antiviral compounds.
MX2010005631A (en) Novel cyclic hydrocarbon compounds for the treatment of diseases.
HRP20110800T1 (en) Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
MX2009003372A (en) Non-mucoadhesive film dosage forms.
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
EP2043637A4 (en) Methods and medicaments for administration of ibuprofen
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
EA200800075A1 (en) DOSING CIRCUIT FOR WISE
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
MX2009003532A (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin.
MD20060037A (en) Method of treating the acute viral hepatitis C
MD3446F1 (en) Method of HIV infection treatment
MD3121G2 (en) Method of viral hepatitis B prophylaxis
AR048068A1 (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETRIOSIS
RU2013129824A (en) NEW TREATMENT OF HEPATITIS C VIRUS INFECTION
RU2013148539A (en) ALISPORIVIR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees